A detailed history of Lmr Partners LLP transactions in Medtronic PLC stock. As of the latest transaction made, Lmr Partners LLP holds 100,871 shares of MDT stock, worth $9.13 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
100,871
Previous 91,600 10.12%
Holding current value
$9.13 Million
Previous $7.21 Million 25.97%
% of portfolio
0.08%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$76.84 - $91.03 $7.75 Million - $9.18 Million
100,871 New
100,871 $9.08 Million
Q4 2023

Feb 14, 2024

BUY
$69.43 - $83.43 $991,946 - $1.19 Million
14,287 Added 49.66%
43,058 $3.55 Million
Q3 2023

Nov 14, 2023

BUY
$78.22 - $90.4 $2.25 Million - $2.6 Million
28,771 New
28,771 $2.25 Million
Q2 2022

Aug 15, 2022

SELL
$87.4 - $113.09 $372,935 - $482,555
-4,267 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$100.58 - $112.38 $429,174 - $479,525
4,267 New
4,267 $473,000
Q2 2021

Aug 16, 2021

SELL
$118.19 - $131.5 $1.35 Million - $1.5 Million
-11,424 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$111.18 - $119.74 $1.27 Million - $1.37 Million
11,424 New
11,424 $1.35 Million
Q1 2020

May 15, 2020

SELL
$72.92 - $121.3 $1.25 Million - $2.08 Million
-17,188 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$104.49 - $114.54 $1.03 Million - $1.13 Million
9,853 Added 134.33%
17,188 $1.95 Million
Q3 2019

Nov 14, 2019

BUY
$98.02 - $111.18 $718,976 - $815,505
7,335 New
7,335 $797,000
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $6.12 Million - $7.22 Million
-72,700 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$82.45 - $93.79 $5.41 Million - $6.15 Million
65,620 Added 926.84%
72,700 $6.62 Million
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $607,464 - $704,389
7,080 New
7,080 $644,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.